Compare VRDN & KWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRDN | KWR |
|---|---|---|
| Founded | 2006 | 1918 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.7B |
| IPO Year | 2014 | 1994 |
| Metric | VRDN | KWR |
|---|---|---|
| Price | $30.42 | $141.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 5 |
| Target Price | $41.17 | ★ $152.50 |
| AVG Volume (30 Days) | ★ 1.2M | 159.5K |
| Earning Date | 05-25-2026 | 05-26-2026 |
| Dividend Yield | N/A | ★ 1.44% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,706,000.00 | ★ $1,888,634,000.00 |
| Revenue This Year | $13.90 | $5.05 |
| Revenue Next Year | $284.55 | $4.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.66 |
| 52 Week Low | $9.90 | $95.91 |
| 52 Week High | $34.29 | $183.01 |
| Indicator | VRDN | KWR |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 29.25 |
| Support Level | $21.50 | $129.91 |
| Resistance Level | $33.71 | $143.28 |
| Average True Range (ATR) | 1.60 | 7.54 |
| MACD | 0.26 | -4.31 |
| Stochastic Oscillator | 92.69 | 7.19 |
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.